Niagen Bioscience (NAGE) Stock: Buy, Sell, or Hold?

NAGE - Niagen Bioscience, Inc. Common Stock

MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
$3.04
0.00 (0.16%) ▲
5d: -2.25%
30d: -0.65%
90d: -11.37%
WAIT
LOW Confidence
Protect Your NAGE Gains
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 03, 2026

Get Alerted When NAGE Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 MIXED SIGNALS: NAGE shows conflicting indicators. Wait for confirmation before entering.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: NAGE is currently trading at $3.04, which is considered oversold relative to its 30-day fair value range of $3.04 to $3.21. From a valuation perspective, the stock is trading at a premium (Forward PE: 30.4) compared to its historical average (19.2). At these levels, the market is pricing in 16.6% annual earnings growth.

Technical Outlook: Technically, NAGE is in a strong downtrend. The price is currently testing key support at $3.00. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: NAGE scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $12.08 (+297.5%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $3.04 - $3.21
Company Quality Score 36/100 (SELL)
Volume Confirmation HIGH
Confidence Score 68.1%

Protect Your Profits

Holding NAGE? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BULLISH: Options cheap (IV 0th percentile)
  • BEARISH: Weak technical setup (25/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 297.5% below Wall St target ($12.08)
  • BULLISH: Expecting earnings turnaround to 16.6% growth with -4.3% revenue growth
  • WARNING: Composite score 36/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $3.04 - $3.21
Current vs Trading Range OVERSOLD
Expected Move (7 Days) ±$0.44 (14.6%)

Support & Resistance Levels

Support Level $3.00
Resistance Level $3.30
Current Trend Strong Downtrend
Technical data as of Sep 11, 2026

Fundamental Context

Forward P/E (Next Year Est.) 30.40
Wall Street Target $12.08 (+297.5%)
Revenue Growth (YoY) -4.3%
Earnings Growth (YoY) -75.0%
Profit Margin 12.4%
Valuation Premium vs History +16.6% premium
PE vs Historical 30.4 vs 19.2 STRETCHED
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +16.6% (market-implied from PE analysis)
1-Year Target $3.54 (+17%)
2-Year Target $4.13 (+36%)
3-Year Target $4.82 (+59%)
3-Yr Target (if PE normalizes) (PE: 30→19) PE COMPRESSION $3.04 (+0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 30.4, Growth: 11.1%) $4.17 (+37%)
Base: (SPY PE: 20.2, Growth: 11.1%) $2.77 (-9%)
Bear: (PE: 17.1, Growth: 11.1%) $2.35 (-23%)
📈 Valuation based on Current Earnings
Trailing PE: 15.97 | Current EPS (TTM): $0.19
Bull Case $1.76 (-42%)
Analyst growth -47.4%, PE expands to 17.6
Base Case $1.60 (-48%)
Market implied -47.4%, PE stable at 16.0
Bear Case $2.06 (-32%)
Severe decline -20.0%, PE contracts to 13.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: September 14, 2026 12:53 AM ET
Data refreshes hourly during market hours. Next update: 1:53 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for NAGE.

Create Free Account

Already have an account? Log In

Top Rated Packaged Foods Stocks

Top-rated stocks in Packaged Foods by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
FRPT
Freshpet Inc
STRONG BUY
19 analysts
$84 34 SELL
DAR
Darling Ingredients Inc
STRONG BUY
13 analysts
$81 44 HOLD
BRBR
Bellring Brands LLC
STRONG BUY
17 analysts
$15 37 SELL
KHC
The Kraft Heinz Company
SELL
23 analysts
$25 56 HOLD
NOMD
Nomad Foods Ltd
STRONG BUY
7 analysts
$14 49 HOLD

Advanced NAGE Option Strategies

Professional options setups generated by AI based on today's NAGE price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for NAGE

NAGE Technical Chart NAGE Price Prediction NAGE Earnings Date NAGE Investment Advisor NAGE Fair Price Analyzer NAGE Options Advisor NAGE Options Chain NAGE Options Analysis NAGE Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals